Integer Holdings beats Q3 sales, profit estimates
Integer Holdings reported Q3 2025 sales of $468 million, an 8% increase, surpassing analyst expectations. Adjusted EPS rose 25% to $1.79. The company forecasts 2025 sales between $1.840 billion and $1.854 billion, with adjusted EPS of $6.29 to $6.43. Growth was driven by a 15% increase in Cardio & Vascular sales, while Neuromodulation saw growth offset by a decline in spinal cord stimulation. The average analyst rating is "buy," with a 12-month price target of $137.50, reflecting a potential 21.5% increase from the recent closing price of $107.94.
)
Overview
- Integer Q3 2025 sales rose 8% to $468 mln, beating analysts’ expectations
- Adjusted EPS for Q3 2025 increased 25% to $1.79, beating consensus
Outlook
- Integer expects 2025 sales between $1.840 bln and $1.854 bln
- Company anticipates 2025 adjusted EPS of $6.29 to $6.43
- Integer forecasts 2026 organic sales flat to up 4%
Result Drivers
- CARDIO & VASCULAR GROWTH - Sales increased 15% driven by new product ramps and acquisitions in electrophysiology and neurovascular
- NEUROMODULATION GROWTH - Growth driven by emerging neuromodulation customers with PMA products, offset by planned decline in spinal cord stimulation
- OTHER MARKETS DECLINE - Sales decreased 16% due to planned multi-year exit from portable medical market
Key Details
Metric Beat/Mis Actual Consensu
s s
Estimate
Q3 Sales Beat $468 mln $466.45
mln (9
Analysts
)
Q3 Beat $1.79 $1.67 (8
Adjusted Analysts
EPS )
Q3 Beat $63 mln $59.80
Adjusted mln (7
Net Analysts
Income )
Analyst Coverage
- The current average analyst rating on the shares is “buy” and the breakdown of recommendations is 9 “strong buy” or “buy”, 2 “hold” and no “sell” or “strong sell”
- The average consensus recommendation for the advanced medical equipment & technology peer group is “buy”
- Wall Street’s median 12-month price target for Integer Holdings Corp is $137.50, about 21.5% above its October 21 closing price of $107.94
- The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 18 three months ago
Press Release: For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact . (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
